ESZOP tablets (Eszopiclone) | Lunesta | Used to Treat Insomnia
ESZOP Tablets (Eszopiclone) – Lunesta – A non-benzodiazepine sleep medicine used to treat insomnia by helping you fall asleep faster, stay asleep longer, and improve sleep quality. Should be taken only under medical supervision due to risk of dependence and side effects.
Product Overview
ESZOP Tablet is a potent non-benzodiazepine hypnotic medication containing Eszopiclone. It belongs to the class of drugs known as sedative-hypnotics and is specifically designed to treat various forms of insomnia. Unlike older sleep medications, it is formulated to assist with both the onset of sleep (falling asleep) and sleep maintenance (staying asleep), providing a comprehensive solution for disrupted rest patterns.
Product Composition
- Active Ingredient: Eszopiclone
- Common Strengths: 1 mg, 2 mg, and 3 mg
- Pharmacological Class: Non-benzodiazepine Hypnotic (S-isomer of Zopiclone)
- Inactive Components: May include lactose, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.
Product Specification
| Feature | Details |
| Brand Name | ESZOP |
| Active Molecule | Eszopiclone |
| Dosage Form | Film-Coated Tablet |
| Primary Indication | Insomnia (Difficulty falling or staying asleep) |
| Typical Duration | Short-term to intermediate use |
| Storage | Store at room temperature (20°C to 25°C); protect from light |
Mechanism of Action
ESZOP works by interacting with the central nervous system to induce and sustain sedation. The process involves:
- GABA Receptor Modulation: Eszopiclone binds to GABA-A receptor complexes at binding sites located near benzodiazepine receptors.
- Neuronal Inhibition: By enhancing the effects of GABA (an inhibitory neurotransmitter), it decreases overall neuronal excitability, leading to a calming effect on the brain.
- Sleep Cycle Promotion: It helps decrease sleep latency (the time it takes to fall asleep) and reduces wakefulness after sleep onset, leading to a more continuous night of rest.
- Selective Binding: As a non-benzodiazepine, it has a more targeted interaction with specific receptor subunits, which is intended to provide sedative benefits with a potentially lower risk of certain side effects compared to traditional benzodiazepines.
Key Benefits
- Dual Action: Effectively addresses both sleep initiation and sleep maintenance, helping patients stay asleep for a full 7 to 8 hours.
- Improved Sleep Quality: Enhances the overall depth and restorative nature of sleep, leading to better daytime alertness.
- Flexible Dosing: Available in multiple strengths (1 mg to 3 mg) to allow for precise titration based on the patient's age and the severity of their insomnia.
- Long-Term Efficacy: Clinical studies have shown it can remain effective for longer periods of use compared to some other hypnotic agents.
- Minimal Next-Day Grogginess: When taken as directed with a full night's sleep, it is designed to have a shorter half-life, reducing the "hangover" effect the following morning.
- Reduction in Nighttime Awakenings: Significantly decreases the frequency of waking up during the night, ensuring a more stable circadian rhythm.
Precautions
General Safety Guidelines
- Use ESZOP Tablet exactly as prescribed for insomnia and sleep disorders
- Take the tablet just before bedtime with at least 7–8 hours available for sleep
- Do not crush, chew, or split the tablet unless advised
Allergy and Sensitivity
- Avoid use if allergic to Eszopiclone or any ingredients in ESZOP Tablet
- Discontinue immediately and seek medical attention if you experience:
- Rash
- Itching
- Swelling
- Difficulty breathing
Use in Special Populations
- Use cautiously in elderly patients; may increase risk of falls or confusion
- Consult your doctor if pregnant or breastfeeding
- Not recommended for children under 18 years
Health and Medical Considerations
| Condition | Precautions |
|---|---|
| Liver disease | Use with caution; may require dose adjustment |
| Kidney disease | May require monitoring; adjust dosage if needed |
| Respiratory disorders | Use cautiously in patients with sleep apnea or breathing problems |
| Mental health conditions | May worsen depression, anxiety, or suicidal thoughts; monitor closely |
| History of substance abuse | Higher risk of dependency or misuse; follow medical guidance |
Drug and Lifestyle Considerations
- Inform your doctor about all medications or supplements you are taking, especially sedatives or alcohol
- Avoid alcohol while taking ESZOP Tablet, as it increases sedation
- Do not drive or operate machinery after taking the tablet
Administration and Storage Guidelines
- Take ESZOP Tablet immediately before bedtime
- Store in a cool, dry place away from direct sunlight
- Keep out of reach of children
- Do not use expired tablets
Usage
ESZOP Tablets are high-potency sedative-hypnotics that must be administered with careful timing to ensure patient safety and drug efficacy. Because Eszopiclone acts rapidly on the central nervous system, it is strictly intended for use immediately before a full night's rest.
Dosage and Administration
The successful use of this medication depends on aligning the dose with the user's age and the required duration of sleep. To avoid next-day impairment, a minimum sleep window is mandatory.
Method of Intake: Tablets should be swallowed whole with water. They should not be crushed or chewed, as this can alter the absorption rate and cause a bitter taste in the mouth.
Timing: Take the dose immediately before bedtime. Do not take it while you are still active or performing tasks, as the sedative effect begins within 15 to 30 minutes.
Sleep Requirement: Only take a dose if you are certain you can stay in bed for a full 7 to 8 hours. Waking up earlier than this increases the risk of memory loss and motor impairment.
Food Interactions: Avoid taking ESZOP with or immediately after a high-fat meal, as this significantly delays the onset of sleep.
Consistency: Use only as needed for sleep disturbances. If used nightly for an extended period, do not stop abruptly, as this may cause rebound insomnia.
Missed Dose: If you forget to take it at bedtime and cannot get a full 7 to 8 hours of sleep before waking, skip the dose entirely and resume the next night.
Administration Guidelines
| Purpose of Treatment | Target Group | Standard Starting Schedule |
| Difficulty Falling Asleep | Non-Elderly Adults | 2 mg or 3 mg immediately before bed |
| Difficulty Staying Asleep | Non-Elderly Adults | 3 mg immediately before bed |
| Geriatric Sleep Support | Elderly Patients | 1 mg immediately before bed |
| Hepatic Impairment | Patients with Liver Issues | 1 mg (max 2 mg) before bed |
Uses
The clinical application of ESZOP focuses on the short-term and intermediate management of sleep disorders by stabilizing the brain's internal rest-activity cycle.
Treatment of Transient Insomnia: Used for temporary sleep disruptions caused by situational stress or changes in environment.
Management of Chronic Insomnia: Indicated for long-term sleep issues where the patient struggles to initiate or maintain sleep over several months.
Reduction of Sleep Latency: Specifically used to decrease the time it takes for a patient to transition from full wakefulness to deep sleep.
Improvement of Sleep Maintenance: Helps patients who wake up frequently during the night or too early in the morning to stay asleep longer.
Restoration of Sleep Quality: Enhances the restorative value of sleep, leading to improved daytime physical and cognitive performance.
Circadian Rhythm Stabilization: Assists in resetting the internal clock for individuals whose sleep patterns have been severely fragmented.
Side Effects
Common Side Effects
- Drowsiness or daytime sleepiness
- Dizziness or lightheadedness
- Headache
- Unpleasant taste in mouth
Less Common Side Effects
- Fatigue or weakness
- Dry mouth
- Nausea or upset stomach
- Memory problems or confusion
Rare but Serious Side Effects
- Severe allergic reactions such as rash, swelling, or difficulty breathing
- Hallucinations or unusual thoughts
- Sleepwalking or performing activities while not fully awake
- Severe depression or suicidal thoughts
- Breathing difficulties, especially in patients with sleep apnea
Health Monitoring Table
| System / Condition | Potential Side Effects |
|---|---|
| Nervous System | Drowsiness, dizziness, headache, memory issues |
| Gastrointestinal System | Nausea, dry mouth, upset stomach |
| Psychological / Mental | Confusion, hallucinations, mood changes, sleepwalking |
| Respiratory System | Breathing difficulties, especially in sleep apnea |
| Allergic Reactions | Rash, swelling, severe allergic response |
| General Effects | Fatigue, weakness, unpleasant taste |
Recommendations
- Take ESZOP Tablet exactly as prescribed for insomnia and sleep disorders
- Avoid driving, operating machinery, or performing tasks requiring alertness after taking the tablet
- Report any severe or persistent side effects to your doctor immediately
- Monitor for unusual sleep behaviors, mood changes, or allergic reactions during treatment
- Ensure at least 7–8 hours of sleep after taking ESZOP Tablet to minimize daytime drowsiness
FAQs
Q: How soon should I take ESZOP before going to bed?
A: You should take ESZOP immediately before getting into bed. It works very quickly, usually within 15 to 30 minutes. Do not take it unless you are ready to sleep and can remain in bed for a full 7 to 8 hours.
Q: Can I take ESZOP with a heavy meal?
A: It is best to avoid taking this medication with or immediately after a high-fat meal. High-fat content can slow down the absorption of the drug, meaning it may take much longer to work and you may not fall asleep as quickly as expected.
Q: What is the most common side effect of ESZOP?
A: Many users report a metallic or bitter taste in the mouth shortly after taking the tablet or the next morning. This is a known characteristic of Eszopiclone and usually resolves once the medication is discontinued.
Q: Does ESZOP cause next-day grogginess?
A: If you get a full 7 to 8 hours of sleep, the risk of "hangover" effects is minimized. However, if you have to wake up early, you may experience impaired alertness, dizziness, or difficulty driving. Do not drive or operate machinery until you feel fully awake.
Q: Is ESZOP habit-forming?
A: ESZOP is a controlled substance because it carries a risk of dependency and abuse. It is intended for short-term or intermediate use. Long-term use should be strictly monitored by a professional to prevent withdrawal symptoms upon stopping.
Q: Can I drink alcohol while taking this medication?
A: No. Alcohol significantly increases the sedative effects of Eszopiclone. Combining the two can lead to dangerous levels of respiratory depression, extreme drowsiness, and complex sleep behaviors.
Q: What are "complex sleep behaviors"?
A: In rare cases, users may engage in activities while not fully awake, such as sleep-walking, sleep-driving, or preparing food, with no memory of the event. If this occurs, the medication should be stopped immediately.
Q: Why is the starting dose lower for elderly patients?
A: Older adults are more sensitive to the effects of hypnotics. A lower starting dose (usually 1 mg) is used to reduce the risk of motor impairment, confusion, and falls during the night or the following morning.
Interactions
Drug Interactions
- Inform your doctor if you are taking any of the following while using ESZOP Tablet:
- Other sedatives or sleep medications
- Alcohol or recreational drugs that depress the central nervous system
- Anti-anxiety medications (benzodiazepines)
- Certain antidepressants or antipsychotics
- Muscle relaxants or pain medications that cause drowsiness
- Combining Eszopiclone with these drugs may:
- Increase sedation or drowsiness
- Impair coordination or reaction time
- Heighten risk of respiratory depression
- Increase chances of memory or cognitive issues
Food and Lifestyle Interactions
- Avoid alcohol while taking ESZOP Tablet
- Maintain consistent sleep schedules for optimal effect
- Avoid driving, operating machinery, or performing tasks requiring alertness after taking the tablet
Health Condition Interactions
| Condition | Interaction Precautions |
|---|---|
| Respiratory disorders | Use cautiously in patients with sleep apnea or chronic lung disease |
| Liver disease | Metabolism may be affected; dose adjustments may be required |
| Kidney disease | May prolong drug effect; monitor closely |
| Mental health conditions | May worsen depression, anxiety, or suicidal thoughts |
| History of substance abuse | Higher risk of dependency or misuse; follow medical guidance |
Other Considerations
- Inform your doctor about all medications, supplements, or herbal products you are using
- Do not start or stop any medication while taking ESZOP Tablet without medical advice
- Monitor for unusual sedation, confusion, or coordination problems during treatment
| Manufacturer | : | Win-Medicare Pvt Ltd |
| Trade Name | : | Lunesta |
| Generic Search | : | Eszopiclone |
| Strength | : | 1mg, 2mg, 3mg |
Latest Products
